Literature DB >> 6431121

Long-term follow-up of transsphenoidal selective adenomectomy for prolactinoma.

E F Rodman, M E Molitch, K D Post, B J Biller, S Reichlin.   

Abstract

Although transsphenoidal selective resection of prolactinoma has high cure rates and low morbidity, the frequency of late recurrence of adenoma is controversial. Long-term follow-up data were available on 29 of our patients having initial return to normal prolactin levels after microadenoma resection; in 24, prolactin levels remained normal at 50 +/- 3 months' (range, 11 to 81 months) follow-up. Five patients manifested hyperprolactinemia again after intervals of six to 16 months. In five patients with normal prolactin levels immediately after macroadenoma resection, who were available for long-term follow-up, prolactin levels remained normal in four at 41 +/- 3 months; one patient had a relapse 78 months after surgery. Testing of prolactin secretory dynamics six weeks postoperatively was not predictive of who would suffer relapse. It is not known whether these relapses are due to regrowth of tumor remnants or represent new tumor formation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6431121

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  14 in total

1.  Treatment of presumed prolactinoma by transsphenoidal operation: early and late results.

Authors:  J A Thomson; G M Teasdale; D Gordon; D C McCruden; D L Davies
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-30

2.  Enlarged adenomectomy for enclosed prolactinomas: a preliminary study of 26 cases.

Authors:  F Grisoli; T Brue; N Graziani; R Costa; J Trouillas; D Begou; P Jaquet
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

3.  Advances in diagnosing and managing pituitary adenomas.

Authors:  M H Samuels
Journal:  West J Med       Date:  1995-04

4.  The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus.

Authors:  Hussam Abou-Al-Shaar; Arka N Mallela; Aneek Patel; Rimsha K Shariff; Samuel S Shin; Phillip A Choi; Amir H Faraji; Pouneh K Fazeli; Tina Costacou; Eric W Wang; Juan C Fernandez-Miranda; Carl H Snyderman; Paul A Gardner; Georgios A Zenonos
Journal:  Pituitary       Date:  2022-04-25       Impact factor: 4.107

5.  Present status of neurosurgery in the treatment of prolactinomas.

Authors:  R Fahlbusch; M Buchfelder
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

6.  Twenty-four-hour prolactin secretory patterns in women with galactorrhea, normal menses, normal random prolacting levels and abnormal sellar tomograms.

Authors:  L P Kapcala; M E Molitch; J Arno; L W King; S Reichlin; S M Wolpert
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

7.  Bromocriptine-induced schizophrenia.

Authors:  S A Peter; A Autz; M L Jean-Simon
Journal:  J Natl Med Assoc       Date:  1993-09       Impact factor: 1.798

8.  Surgical treatment of microprolactinomas: pros.

Authors:  Roberto Salvatori
Journal:  Endocrine       Date:  2014-05-15       Impact factor: 3.633

Review 9.  Diagnosis and drug therapy of prolactinoma.

Authors:  E Ciccarelli; F Camanni
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

10.  Management of selected patients with hyperprolactinaemia by partial hypophysectomy.

Authors:  M F Scanlon; J R Peters; J P Thomas; S H Richards; W H Morton; S Howell; E D Williams; M Hourihan; R Hall
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.